Phosphoric acid, also known as orthophosphoric acid, is used in dentistry and orthodontics to clean and roughen the surfaces of teeth where dental appliances or fillings will be placed. In addition, this acid is a part of product ProcalAmine, which is indicated for peripheral administration in adults to preserve body protein and improve nitrogen balance in well-nourished, mildly catabolic patients who require short-term parenteral nutrition. In combination with dextrose (glucose) and levulose (fructose), phosphoric acid relieves nausea due to upset stomach from intestinal flu, stomach flu, and food or drink indiscretions. In addition, homeopathic product, Brain power contains also phosphoric acid and this product is used to temporarily relieve symptoms of general physical weakness and listlessness, including: fatigue; sore muscles & joints; dry skin; absence of sexual desire; occasional sleeplessness.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Palliative | PROCALAMINE Approved UseProcalAmine is indicated for peripheral administration in adults to preserve body protein and improve nitrogen balance in well-nourished, mildly catabolic patients who require short-term parenteral nutrition. Launch Date1982 |
|||
| Palliative | Unknown Approved UseUnknown |
|||
| Palliative | Unknown Approved UseUnknown |
|||
| Palliative | Unknown Approved UseUnknown |
|||
| Palliative | Unknown Approved UseUnknown |
|||
| Diagnostic | Unknown Approved UseUnknown |
|||
| Diagnostic | Unknown Approved UseUnknown |
|||
| Primary | SODIUM PHOSPHATES INJECTION Approved UseSodium Phosphates Injection, USP, 3mM P/mL, is indicated as a source of phosphorus, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. The concomitant amount of sodium (4 mEq/mL) must be calculated into total electrolyte content of such prepared solutions. |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Diurnal variation in the levels of glucose and related substances in healthy and diabetic subjects during starvation. | 1967 Feb |
|
| Determination of inorganic phosphate in serum and saliva using a synthetic receptor. | 2003 Jun 12 |
|
| Amperometric biosensor for determining human salivary phosphate. | 2005 Aug 15 |
|
| Phosphorus amendment reduces hepatic and renal oxidative stress in mallards ingesting lead-contaminated sediments. | 2006 Jun |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
B05XA09
Created by
admin on Fri Dec 15 16:31:02 GMT 2023 , Edited by admin on Fri Dec 15 16:31:02 GMT 2023
|
||
|
WHO-VATC |
QA06AG01
Created by
admin on Fri Dec 15 16:31:02 GMT 2023 , Edited by admin on Fri Dec 15 16:31:02 GMT 2023
|
||
|
WHO-VATC |
QB05XA09
Created by
admin on Fri Dec 15 16:31:02 GMT 2023 , Edited by admin on Fri Dec 15 16:31:02 GMT 2023
|
||
|
WHO-ATC |
A06AD17
Created by
admin on Fri Dec 15 16:31:02 GMT 2023 , Edited by admin on Fri Dec 15 16:31:02 GMT 2023
|
||
|
WHO-ATC |
A06AG01
Created by
admin on Fri Dec 15 16:31:02 GMT 2023 , Edited by admin on Fri Dec 15 16:31:02 GMT 2023
|
||
|
WHO-VATC |
QA06AD17
Created by
admin on Fri Dec 15 16:31:02 GMT 2023 , Edited by admin on Fri Dec 15 16:31:02 GMT 2023
|
||
|
DSLD |
2920 (Number of products:88)
Created by
admin on Fri Dec 15 16:31:02 GMT 2023 , Edited by admin on Fri Dec 15 16:31:02 GMT 2023
|
||
|
NCI_THESAURUS |
C29730
Created by
admin on Fri Dec 15 16:31:02 GMT 2023 , Edited by admin on Fri Dec 15 16:31:02 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
37586
Created by
admin on Fri Dec 15 16:31:02 GMT 2023 , Edited by admin on Fri Dec 15 16:31:02 GMT 2023
|
PRIMARY | |||
|
SE337SVY37
Created by
admin on Fri Dec 15 16:31:02 GMT 2023 , Edited by admin on Fri Dec 15 16:31:02 GMT 2023
|
PRIMARY | |||
|
SE337SVY37
Created by
admin on Fri Dec 15 16:31:02 GMT 2023 , Edited by admin on Fri Dec 15 16:31:02 GMT 2023
|
PRIMARY | |||
|
DTXSID3037674
Created by
admin on Fri Dec 15 16:31:02 GMT 2023 , Edited by admin on Fri Dec 15 16:31:02 GMT 2023
|
PRIMARY | |||
|
37583
Created by
admin on Fri Dec 15 16:31:02 GMT 2023 , Edited by admin on Fri Dec 15 16:31:02 GMT 2023
|
PRIMARY | |||
|
7632-05-5
Created by
admin on Fri Dec 15 16:31:02 GMT 2023 , Edited by admin on Fri Dec 15 16:31:02 GMT 2023
|
PRIMARY | |||
|
CHEMBL1060
Created by
admin on Fri Dec 15 16:31:02 GMT 2023 , Edited by admin on Fri Dec 15 16:31:02 GMT 2023
|
PRIMARY | |||
|
4219
Created by
admin on Fri Dec 15 16:31:02 GMT 2023 , Edited by admin on Fri Dec 15 16:31:02 GMT 2023
|
PRIMARY | |||
|
231-558-5
Created by
admin on Fri Dec 15 16:31:02 GMT 2023 , Edited by admin on Fri Dec 15 16:31:02 GMT 2023
|
PRIMARY | |||
|
Sodium Phosphate
Created by
admin on Fri Dec 15 16:31:02 GMT 2023 , Edited by admin on Fri Dec 15 16:31:02 GMT 2023
|
PRIMARY | |||
|
36709
Created by
admin on Fri Dec 15 16:31:02 GMT 2023 , Edited by admin on Fri Dec 15 16:31:02 GMT 2023
|
PRIMARY | RxNorm | ||
|
SUB12587MIG
Created by
admin on Fri Dec 15 16:31:02 GMT 2023 , Edited by admin on Fri Dec 15 16:31:02 GMT 2023
|
PRIMARY | |||
|
C018279
Created by
admin on Fri Dec 15 16:31:02 GMT 2023 , Edited by admin on Fri Dec 15 16:31:02 GMT 2023
|
PRIMARY | |||
|
C29459
Created by
admin on Fri Dec 15 16:31:02 GMT 2023 , Edited by admin on Fri Dec 15 16:31:02 GMT 2023
|
PRIMARY |
One of these components may be present:
ACTIVE MOIETY
SUBSTANCE RECORD
